Captrust Financial Advisors Meira G Tx Holdings PLC Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.21 - $5.81 $42,104 - $58,105	10,001 New	10,001 $42,000
Q2 2022 Aug 16, 2022	SELL	$6.8 - $14.23 $53,400 - $111,748	-7,853 Reduced 63.96%	4,425 $33,000
Q1 2022 May 16, 2022	SELL	$13.42 - $23.38 $800,100 - $1.39 Million	-59,620 Reduced 82.92%	12,278 $170,000
Q4 2021 Feb 14, 2022	BUY	$12.78 - $23.74 $918,498 - $1.71 Million	71,870 Added 256678.56%	71,898 $1.71 Million
Q1 2021 May 17, 2021	BUY	$13.84 - $17.8 $387 - $498	28 New	28 $0

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $283M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.